3 ASX Dividend Stocks Yielding Up To 5.3%
As the Australian market navigates the impacts of rising oil prices and fluctuating indices, investors are increasingly looking towards dividend stocks as a stable income source amidst economic uncertainty. In this environment, selecting stocks with reliable dividend yields can be an effective strategy for those seeking to balance potential inflationary pressures with steady returns.
Top 10 Dividend Stocks In Australia
| Name | Dividend Yield | Dividend Rating |
| Vita Life Sciences (ASX:VLS) | 5.38% | ★★★★★☆ |
| Sugar Terminals (NSX:SUG) | 9.51% | ★★★★★☆ |
| Steadfast Group (ASX:SDF) | 3.52% | ★★★★★☆ |
| Peet (ASX:PPC) | 7.18% | ★★★★★☆ |
| Objective (ASX:OCL) | 3.65% | ★★★★★☆ |
| Kina Securities (ASX:KSL) | 8.46% | ★★★★★☆ |
| Jumbo Interactive (ASX:JIN) | 7.13% | ★★★★★☆ |
| Fiducian Group (ASX:FID) | 5.93% | ★★★★★☆ |
| EQT Holdings (ASX:EQT) | 5.32% | ★★★★★☆ |
| Dicker Data (ASX:DDR) | 3.46% | ★★★★☆☆ |
Click here to see the full list of 28 stocks from our Top ASX Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Commonwealth Bank of Australia (ASX:CBA)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Commonwealth Bank of Australia provides retail and commercial banking services across Australia, New Zealand, and internationally, with a market cap of A$271.89 billion.
Operations: Commonwealth Bank of Australia's revenue segments include Retail Banking Services (Incl. Bankwest) at A$13.41 billion, Business Banking at A$9.74 billion, New Zealand operations at A$2.95 billion, and Institutional Banking and Markets at A$2.94 billion.
Dividend Yield: 3.1%
Commonwealth Bank of Australia's dividend strategy shows mixed results for investors. Despite a recent increase in dividends, the bank's payments have been volatile over the past decade. The dividend yield remains modest compared to top-tier Australian payers, yet dividends are currently covered by earnings with a 77.4% payout ratio and are expected to remain sustainable over the next three years. Recent financial results show net income growth, supporting future dividend payments amid ongoing strategic initiatives like buybacks and fixed-income offerings.
- Dive into the specifics of Commonwealth Bank of Australia here with our thorough dividend report.
- Our valuation report unveils the possibility Commonwealth Bank of Australia's shares may be trading at a premium.
Computershare (ASX:CPU)
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Computershare Limited offers a range of services including issuer services, corporate trust, employee share plans, communication and utilities technology, and mortgage and property rental services, with a market cap of A$22.96 billion.
Operations: Computershare Limited's revenue is primarily derived from its Corporate Trust segment at $1.03 billion, Issuer Services at $1.33 billion, and Employee Share Plans at $585.50 million.
Dividend Yield: 3.3%
Computershare's recent announcement of an A$0.65 dividend per share highlights a modest yield in the Australian market, with dividends covered by earnings and cash flows at payout ratios of 77.6% and 66.3%, respectively. Despite past volatility in payments, dividends have grown over the last decade, supported by steady revenue growth to US$3.22 billion for fiscal year 2026. However, client losses may impact future stability and growth prospects for dividend investors.
- Navigate through the intricacies of Computershare with our comprehensive dividend report here.
- Insights from our recent valuation report point to the potential undervaluation of Computershare shares in the market.
Vita Life Sciences (ASX:VLS)
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Vita Life Sciences Limited is a healthcare company that formulates, packages, distributes, and sells vitamins and supplements across Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China with a market cap of A$141.39 million.
Operations: Vita Life Sciences Limited generates its revenue by formulating, packaging, distributing, and selling vitamins and supplements across several countries in the Asia-Pacific region.
Dividend Yield: 5.4%
Vita Life Sciences' dividend is supported by a 69.2% payout ratio, indicating sustainability through earnings and cash flows. Despite trading below estimated fair value, recent insider selling raises caution. The company reported A$5.56 million net income for the half year ended June 2026, showing growth from A$4.84 million previously. Dividends have been stable and increased over the past decade but remain lower than top-tier Australian yields at 5.38%. An ongoing share buyback program may enhance shareholder value further.
- Take a closer look at Vita Life Sciences' potential here in our dividend report.
- Our comprehensive valuation report raises the possibility that Vita Life Sciences is priced lower than what may be justified by its financials.
Where To Now?
- Unlock more gems! Our Top ASX Dividend Stocks screener has unearthed 25 more companies for you to explore.Click here to unveil our expertly curated list of 28 Top ASX Dividend Stocks.
- Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
- Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com